Zika Virus Infection
- Home
- Infectious Diseases
- Zika Virus Infection
Developing advanced diagnostic tools is critical to effectively combating Zika virus. With our groundbreaking research on Zika virus infection, we lead the way in creating cutting-edge IVD solutions to enhance the efficient management of Zika virus infection. Serving as your trusted ally in Zika virus infection diagnostic research, we offer unmatched support to fulfill your scientific research requirements.
Zika virus, a member of the Flaviviridae family, has gained significant attention due to its impact on global health. Transmitted primarily through Aedes mosquitoes and occasionally through sexual contact and blood transfusions, Zika poses a particular threat to pregnant individuals and their fetuses. The virus, often asymptomatic or presenting mild symptoms in non-pregnant individuals, can lead to severe congenital conditions like microcephaly and improper brain development in fetuses.
Fig. 1 Metabolic disorders caused by Zika virus infection. (Yau, Clement, et al., 2021)
Zika virus infection presents unique challenges due to its diverse presentation and potentially severe consequences, especially for pregnant women and fetuses. Accurate diagnostic biomarkers are essential for the timely detection, management, and control of Zika virus infection.
Viral RNA
Viral RNA can be identified in blood, urine, and other body fluids during the acute phase of infection, providing a direct indicator of active Zika virus presence. Detection of Zika virus RNA through RT-PCR technology is a primary diagnostic approach.
Antigens
Zika virus specific antigens, such as envelope and capsid proteins, are important diagnostic biomarkers. Antigen detection using immunoassays is rapid and sensitive and can identify Zika virus infection as early as possible.
Antibodies
IgM antibodies are usually present during the acute phase of infection, while IgG antibodies indicate past infection with the virus. Serological testing plays a vital role in confirming Zika virus infection and assessing immune responses.
In vitro diagnostic (IVD) kits are an indispensable tool for diagnosing Zika virus infection. These kits help accurately and quickly diagnose Zika virus infection and differentiate it from other diseases with similar symptoms, allowing for targeted therapeutics and control measures.
Kits | Applications | Detection Methods |
Zika Virus RT-PCR Detection Kit | Detection of Zika virus RNA in blood or other body fluids (such as urine or saliva). | RT-PCR |
Zika Virus IgG Antibody Detection Kit | Qualitative in vitro detection of IgG antibodies specific to the Zika virus in serum and plasma samples. | ELISA |
Zika Virus Antigen Detection Kit | Detection of structural protein antigens of Zika virus, such as envelope and capsid proteins. | Immunochromatographic Assay |
As pioneers in infectious disease diagnostic development, we specialize in delivering innovative IVD solutions tailored for Zika virus infection, addressing intricate diagnostic requirements. Our proficiency centers around crafting specialized IVD reagents/kits and cutting-edge diagnostic devices for Zika virus infection, enhancing diagnostic automation and facilitating efficient disease control.
Our point-of-care testing (POCT) development services are committed to creating fast and easy-to-use diagnostic tools for Zika virus infection, including handheld analyzers and compact diagnostic devices. Our companion diagnostic development services aim to facilitate individualized therapeutics for affected individuals by developing IVD tests and associated devices.
If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
Reference
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.